NR3C1 and neoplasm: To assess the effect of tumor cell-specific GR depletion or pharmacologic GR inhibition on the tumor immune microenvironment, we used time-of-flight mass cytometry (CyTOF) for high-dimensional analysis of tumor-associated immune cells at the single-cell level36,37 (Fig. 4a, b).